BROCCARDO, Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.703
EU - Europa 795
AS - Asia 384
SA - Sud America 41
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.931
Nazione #
US - Stati Uniti d'America 3.678
IN - India 219
SE - Svezia 185
UA - Ucraina 183
IT - Italia 155
FI - Finlandia 131
CN - Cina 111
SG - Singapore 52
AR - Argentina 39
GB - Regno Unito 35
IE - Irlanda 27
BG - Bulgaria 22
CA - Canada 20
AT - Austria 17
BE - Belgio 11
DE - Germania 11
NL - Olanda 7
MX - Messico 4
ZA - Sudafrica 4
CH - Svizzera 3
EU - Europa 3
RO - Romania 3
RU - Federazione Russa 3
CL - Cile 2
ES - Italia 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
MU - Mauritius 1
PR - Porto Rico 1
Totale 4.931
Città #
Fairfield 563
Chandler 420
Ashburn 307
Woodbridge 292
Houston 213
Seattle 197
Wilmington 197
Cambridge 189
Ann Arbor 152
Princeton 121
Plano 120
San Paolo di Civitate 109
Beijing 105
Jacksonville 83
Boston 68
Lawrence 63
San Diego 49
Federal 39
Andover 35
Boardman 30
Dublin 26
Des Moines 25
Millbury 25
Singapore 23
Sofia 22
Norwalk 21
Rome 18
Vienna 17
Toronto 14
Washington 13
Falls Church 12
Brussels 11
Helsinki 11
Los Angeles 10
Dearborn 9
Auburn Hills 8
Bühl 8
Indiana 8
Buffalo 4
Montréal 4
Muizenberg 4
New York 4
Redmond 4
Southend 4
Bern 3
Chicago 3
Monterrey 3
San Mateo 3
Laurel 2
London 2
San Francisco 2
Sassari 2
Almaty 1
Amsterdam 1
Bari 1
Bremen 1
Catania 1
Catford 1
Dalmine 1
Fremont 1
Fuzhou 1
Genova 1
Gorey 1
Hefei 1
Hounslow 1
Kunming 1
Kyiv 1
Leawood 1
Mcallen 1
Milan 1
Montreal 1
Munich 1
Nanjing 1
Ningbo 1
Ottawa 1
Peterborough 1
Philadelphia 1
Phoenix 1
Piediluco 1
Redwood City 1
Riga 1
San Juan 1
Santiago 1
Seversk 1
Stockholm 1
Tappahannock 1
Trumbull 1
Yellow Springs 1
Totale 3.713
Nome #
Neuropeptide S inhibits stress-stimulated faecal output in the rat 103
A rat model of narcotic bowel syndrome 98
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors 92
TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat 82
The hypothalamus-pituitary-adrenal axis does not influence the protective effects of nociceptin/orphanin FQ on the rat gastric mucosa. 82
Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion 76
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis 73
TLQP-21, a VGF-derived peptide, prevents ethanol-induced gastric lesions: Insights into its mode of action 70
Expression of NK-1 and NK-3 tachykinin receptors in pancreatic acinar cells after acute experimental pancreatitis in rats. 69
Sauvagine-induced hypothermia: evidence for an interaction with the dopaminergic system. 68
Central and peripheral role of the nociceptin/orphaninFQ system on normal and disturbed colonic motor function and faecal pellet output in the rat 65
Central and peripheral antiulcer and antisecretory effects of Ala(5)NKA(4-10), a tachykinin NK2 receptor agonist, in rats 64
The brain-gut-skin triangle: New peptides 64
Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differences 63
In vitro and in vivo opioid activity of [DPro(6)]dermorphin, a new dermorphin analogue 63
EFFECT OF SELECTIVE MU(1), MU(2) AND DELTA(2) OPIOID RECEPTOR AGONISTS ON GASTRIC FUNCTIONS IN THE RAT 63
Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig 62
Relative potency of bombesin-like peptides. 61
Role of cannabinoid system in the exocrine pancreas 59
Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII 59
Sauvagine: effects on thermoregulation in the rat. 59
Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide. 59
Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats 58
Adrenal Modulation of the Inhibitory Effect of Sauvagine On Gastric-emptying 58
Evidence of Central and Peripheral Sensitization in a Rat Model of Narcotic Bowel-Like Syndrome 58
The Effect of [Leu8]Litorin, a New Bombesin-like Peptide, on Gastric Functions and Thermoregulation in the Rat 58
Expression of NK-1 and NK-3 tachykinin receptors in pancrestic acinar cells after acute experimental pancreatitis in rats 57
The effects of [Arg(14), Lys(15)] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions 56
TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat 56
Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis 56
Spinal Antinociceptive Effects of [d-ala2]deltorphin-ii, A Novel and Highly Selective Delta-opioid Receptor Agonist 56
Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats 54
Immunocytochemical distribution of NK-1 and NK-3 tachykinin receptors in isolated pancreatic acini of guinea pigs and rats 54
Sauvagine: effects on gastric acid secretion in rats. 54
Tachykinins - Effects On Gastric-secretion and Emptying In Rats 54
Gastric antisecretory effect of sauvagine in rats: Possible mechanisms 54
Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: A comparative study 54
Effect of sauvagine on gastric emptying in conscious rats. 53
Antidiarrheal effect of deltorphin II, a highly selective delta opioid receptor agonist, in the rat. 53
CROSS-TOLERANCE BETWEEN DERMORPHIN AND MORPHINE TO ANALGESIA AND CATALEPSY IN RATS 52
Antinociceptive effect of two amphibian tachykinins, PG-SPI and PG-KII, in the rat tail-flick test. 51
Tachykinins: Role in human gastrointestinal tract physiology and pathology 51
Maternal Exposure to Low Levels of Corticosterone during Lactation Protects against Experimental Inflammatory Colitis-Induced Damage in Adult Rat Offspring 51
Anti-hyperalgesic effect of nociceptin/orphanin FQ in a rat model of narcotic bowel syndrome 50
Effect of PG-SPI and PG-KII, two novel and natural tachykinins, on salivary secretion in the rat 50
Pituitary-adrenal mediation of dermorphin-induced inhibition of gastric emptying in rats. 50
Effects of dermorphin on gastrointestinal transit in rats 49
Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin 48
Sauvagine: inhibition of gastric acid secretion in rats. 48
Effects of supraspinal administration of PG-SPI and PG-KII, two amphibian tachykinin peptides, on nociception in the rat 47
Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors 47
Central effects of selective NK1 and NK3 tachykinin receptor agonists on two models of experimentally-induced colitis in rats 47
Central Neuropeptide S inhibits stress-stimulated defecation in the rat 45
The effects of UFP112, a novel N/OFQ-NOP receptor ligand, on colonic propulsion and defecation in physiological and pathological conditions 44
Anti-nociceptive effects of orphanin FQ in inflammation-induced hyperalgesia in rat 43
Orphanin FQ/nociceptin: effects on gastric acid secretion and emptying in rats. 43
Neural regulation of gastric acid secretion in rats: Influence of dermorphin 43
Farmacologia, azione e reazione dei farmaci 41
In vitro and in vivo biological activities of PG-KII, a novel kassinin-like peptide from the skin of the Australian frog, Pseudophryne guntheri 40
Effect of dermorphin on body temperature in rats. 40
Phyllolitorins: A New Family of Bombesin-like Peptides 40
Aspetti farmacologici della terapia tubercolare 38
The effect of a new amphibian peptide, Leu-8-phyllolitorin, on thermoregulation in the rat. 37
A rat model of narcotic bowel syndrome 37
Tolerance and physical dependence induced by dermorphin in rats 37
Il comportamento del Vip, dell'insulina e della gastrina nella cirrosi epatica prima e dopo shunts porto-sistemici 37
Role of tachykinin NK3 receptor agonists in the control of pancreatic exocrine secretion in vitro 35
The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions 35
Effetti della bombesina e della somatostatina sulla pressione intragastrica nel cane 35
Knockdown of rat brain δ-opioid receptors by antisense oligodeoxynucleotides 34
STIMULATORY EFFECT OF PG-KII, AN NK3 TACHYKININ RECEPTOR AGONIST, ON ISOLATED PANCREATIC ACINI:SPECIES DIFFERENCES. 32
Immunomodulatory role of nociceptin/orphanin FQ - NOP receptor system in a rat model of experimental colitis 32
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide in the regulation of rat motor gastric functions 32
In vitro and in vivo effects of WIN55,212 on exocrine pancreas in physiological condition and during acute pancreatitis 31
Antidiarrheal and Colonic Antipropulsive Effects of Spinal and Supraspinal Administration of the Natural Delta-opioid Receptor Agonist, [d-ala(2)]deltorphin-ii, In the Rat 31
A MODEL OF NARCOTIC BOWEL SYNDROME IN RATS: EVIDENCE OF CENTRAL AND PERIPHERAL SENSITIZATION 31
Central effect of two natural tachykinins, PG-SPI and PG-KII, on experimental colitis in rats. 31
Effects of antisense oligodeoxynucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. 31
Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse 31
Role of delta opioid receptor system in the control of colonic propulsion in rats and mice 30
A comparative study of the effect of (Arg14,Lys15)N/OFQ and deltorphin on exocrine pancreatic secretion in vitro 30
A comparative study of the effect of (Arg 14, Lys 15)N/OFQ and deltorphin on exocrine pancreatic secretion in vitro. 29
Effect of two amphibian tachykinins, PG-SPI and PG-KII, on different models of experimental colitis in rats. 29
Effect of maternal exposure to low levels of corticosterone during lactation on the susceptibility to the TNBS-induced colitis in rat adult male and female offspring 29
The effects of Arg14 Lys15 nociceptin/orphanin FQ, a higly potent agonist of the NOP receptor, on invitro and in vivo gastrointestinal functions. 28
The central and peripheral effects of UFP112, a novel N/OFQ-NOP receptor ligand, on colonic propulsion and defecation in physiological and pathological conditions 27
Involvement of the cannabinoid system in the rat and guinea pig exocrine pancreatic secretion. 27
Novel dermorphin analogues: in vitro and in vivo gastrointestinal effects. 27
Peripheral antinociceptin effect of orphanin/FQ on postinflammatory colorectal hypersensitivity is mediated by an up regulation of N/OFQergic system 26
Effect of a natural NK1 tachykinin receptor agonist, PG-SPI, on two models of experimental colitis in rats. 26
Role of the cannabinoid system in the exocrine pancreas 26
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat motor gastric functions 26
Protocolli di terapia antibiotica 25
Nociceptin/orphaninFQ-induced gastric emptying delay: evidence for a role of limbic-adrenal axis 24
Role of Vasoactive Intestinal Peptide (VIP) on portal haemodinamics before and after end to side porto-caval shunt: experimental study 24
GASTROINTESTINAL EFFECTS OF CENTRALLY INJECTED ORPHANIN FQ/NOCICEPTIN IN RATS. 23
Hypothermic Effect of D-ala-deltorphin-ii, A Selective Delta-opioid Receptor Agonist 23
The effect of orphanin FQ on some in vivo and in vitro gastrointestinal functions. 22
Effect of agonist (Nociceptin/Orphanin FQ) and antagonist (UFP-101) of the NOP receptor system in a rat model of experimental colitis 22
Development of tolerance to the effect of dermorphin on gastric emptying in the rat. 21
Totale 4.668
Categoria #
all - tutte 12.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 110
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019407 0 0 0 0 0 0 0 0 0 0 233 174
2019/20201.156 200 43 14 62 114 117 127 135 123 109 84 28
2020/2021345 51 46 15 35 9 23 6 38 38 48 26 10
2021/20221.031 6 77 114 13 132 21 20 118 99 95 131 205
2022/20231.238 214 240 97 157 137 152 10 54 133 3 27 14
2023/2024335 38 67 21 43 27 58 3 9 0 53 16 0
Totale 4.992